Pharmaceutical Investing EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
EyePoint Pharmaceuticals Reports Fiscal 2018 Fourth Quarter & Full Year Financial Results and Highlights Recent Progress
175m @ 2.5% Copper from 7.6m, Hole Ends in 4.46% Copper & Open at Depth Danvers Drilling Delivers a Globally Significant Copper Intersection
